Iqvia Holdings (IQV) Amortization of Deferred Charges (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Amortization of Deferred Charges came in at $6.0 million in Q2 2026, little changed year-over-year from $6.0 million in Q2 2025, and little changed quarter-over-quarter from $6.0 million in Q1 2026.
Analysis
Iqvia Holdings (IQV) Amortization of Deferred Charges (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Amortization of Deferred Charges across 15 years of filings, most recently posting $6.0 million for Q2 2026.
- In Q2 2026, Amortization of Deferred Charges changed 0.0% year-over-year to $6.0 million; the TTM figure through Jun 2026 stood at $24.0 million (up 14.29% YoY), while the FY2025 annual figure was $23.0 million, up 9.52% from the prior year.
- Amortization of Deferred Charges came in at $6.0 million for Q2 2026 at Iqvia Holdings, roughly flat from $6.0 million in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $6.0 million in Q2 2024 to a low of $3.0 million in Q2 2022.
- Average Amortization of Deferred Charges over 5 years is $4.9 million, with a median of $5.0 million recorded in 2023.
- Year-over-year, Amortization of Deferred Charges slumped 40.0% in 2022 and surged 50.0% in 2024.
- Over 5 years, Amortization of Deferred Charges stood at $4.0 million in 2022, then gained by 25.0% to $5.0 million in 2023, then changed by 0.0% to $5.0 million in 2024, then grew by 20.0% to $6.0 million in 2025, then changed by 0.0% to $6.0 million in 2026.
- Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $6.0 million in Q2 2026, $6.0 million in Q1 2026, and $6.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.00 Mn |
| Mar 31, 2026 | 6.00 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Sep 30, 2025 | 6.00 Mn |
| Jun 30, 2025 | 6.00 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 6.00 Mn |
| Mar 31, 2024 | 5.00 Mn |
| Dec 31, 2023 | 5.00 Mn |
| Sep 30, 2023 | 5.00 Mn |
| Jun 30, 2023 | 4.00 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 4.00 Mn |
| Sep 30, 2022 | 4.00 Mn |
| Jun 30, 2022 | 3.00 Mn |
| Mar 31, 2022 | 4.00 Mn |
| Dec 31, 2021 | 3.00 Mn |
| Sep 30, 2021 | 4.00 Mn |